0001596771-19-000015.txt : 20190227 0001596771-19-000015.hdr.sgml : 20190227 20190227134548 ACCESSION NUMBER: 0001596771-19-000015 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190227 DATE AS OF CHANGE: 20190227 EFFECTIVENESS DATE: 20190227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROONE MEDICAL TECHNOLOGIES Corp CENTRAL INDEX KEY: 0001500198 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 270863354 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-317594 FILM NUMBER: 19636894 BUSINESS ADDRESS: STREET 1: 10006 LIATRIS LANE CITY: EDEN PRAIRIE STATE: MN ZIP: 55347 BUSINESS PHONE: (952) 237-7412 MAIL ADDRESS: STREET 1: 10006 LIATRIS LANE CITY: EDEN PRAIRIE STATE: MN ZIP: 55347 FORMER COMPANY: FORMER CONFORMED NAME: Original Source Entertainment, Inc. DATE OF NAME CHANGE: 20100830 D/A 1 primary_doc.xml X0708 D/A LIVE 0001500198 NEUROONE MEDICAL TECHNOLOGIES Corp 10901 Red Circle Dr. Suite 150 Minnetonka MN MINNESOTA 55343 (952) 237-7412 DELAWARE Original Source Entertainment, Inc. Corporation true David A. Rosa 10901 Red Circle Dr. Suite 150 Minnetonka MN MINNESOTA 55343 Executive Officer Director Thomas Bachinski 19059 Orchard Trail Lakeville MN MINNESOTA 55044 Executive Officer Mark Christianson 10901 Red Circle Dr. Suite 150 Minnetonka MN MINNESOTA 55343 Executive Officer Paul Buckman 10901 Red Circle Dr. Suite 150 Minnetonka MN MINNESOTA 55343 Director Suraj Kalia 10901 Red Circle Drive Suite 150 Minnetonka MN MINNESOTA 55343 Director Jeffrey S. Mathiesen 10901 Red Circle Dr. Suite 150 Minnetonka MN MINNESOTA 55343 Director Biotechnology Decline to Disclose 06b true 0001596771-18-000086 2018-07-09 false true true true false 0 Corinthian Partners, LLC 38912 Mohammad Jainal Bhuiyan 5344937 850 Third Avenue Suite 16C New York NY NEW YORK 10022 FL FLORIDA MD MARYLAND NY NEW YORK TX TEXAS VA VIRGINIA false 10000000 1538000 8462000 Over-allotment amount of $1,500,000 is no longer exercisable. false 21 90240 0 In addition to the cash commission, the brokers will receive a warrant to purchase an amount of common stock equal to 8% of the total amount of shares sold by the broker in the offering. 823140 true The proceeds of this private placement, along with proceeds from other financings, may be used to pay certain executive officers. false NEUROONE MEDICAL TECHNOLOGIES Corp /s/ David A. Rosa David A. Rosa CEO 2019-02-27